Fazirsiran

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

221 competitors in Liver Disease

#DrugCompanyPhaseTrials

1

Mounjaro

Eli Lilly

Phase 3

—2

Inderal

WWyeth-Lederle Vaccines

Phase 3

13

Neurontin

VViatris Specialty LLC

Phase 3

14

Viagra

VViatris Specialty LLC

Phase 3

15

Sandostatin

Sun Pharma

Phase 3

16

Neupogen

EEastern Cooperative Oncology Group

Phase 3

—7

Retatrutide

Eli Lilly

Phase 3

—8

Chronulac

SSolvay Pharmaceuticals

Phase 2

19

Rayos

RRoxane Laboratories

Phase 2

—10

Tenofovir (TFV) IVR

Gilead

Phase 2

1Show 31 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Liver Disease3 trials

An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease

Active, not recruiting·Takeda·Phase 3·NCT05899673·31 enrolled

Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

Recruiting·Takeda·Phase 3·NCT05677971·160 enrolled

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

Recruiting·Takeda·Phase 3·NCT06165341·50 enrolled

Liver1 trial

A Study About Fazirsiran in People With and Without Liver Problems

Completed·Takeda·Phase 1·NCT05891158·34 enrolled

Details

Drug Info

Related News